De novo drug design of multi-targeted chemical libraries based on AI can be used in the process of drug discovery and development in industry and academia. This design based on multi-target allows the generation of new molecular entities with optimized drug-like properties and similarity-based constraints biasing specific biological targets. In addition, this de novo approach to chemical compound library design could be applied and strengthened in combination with other hybrid strategies based on conventional methods and AI [ 72].